Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Quarterly Financial Report Reauthorization Act
Client: CELGENE CORPORATION · Firm: ALSTON & BIRD LLP
Issues relating to prescription drugs in health care bills; orphan drug and rare disease bill; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment Act of 2013 (H.R. 460); MODDERN Cures Act (H.R. 3116); H.R. 5657, the FAST Generics Act of 2014; tax extenders package; 21st Century Cures; H.R. 5780, the Protecting the Integrity of Medicare Act.
Cancer Drug Coverage Parity Act of 2013
Client: CELGENE CORPORATION · Firm: ALSTON & BIRD LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2017 · fourth_quarter · Q4
Issues related to drug policy, including reimbursement.
Issues related to drug policy, including reimbursement.
Source: Senate LDA
| AMERICAN ASSOCIATION OF HIP AND KNEE SURGEONS |
| 4 |
| 2012–2013 |
| INAMED CORP | 4 | 2004–2006 |
| PROSTRAKAN INC | 4 | 2008–2009 |
| CELGENE CORPORATION | 3 | 2014–2015 |
| ADVOCATE HEALTHCARE | 2 | 2005–2006 |
| CSL BEHRING LLC (FORMERLY ZLB BEHRING) | 2 | 2005–2006 |
| DELIVER MED HOLDINGS | 2 | 2005 |
| GENOMIC HEALTH INC | 2 | 2006 |
| ANODYNE THERAPY | 1 | 2005 |
| BNN HOLDINGS CORP | 1 | 2013 |
| BRACCO DIAGNOSTICS INC. | 1 | 2007 |
| GENERIC PHARMACEUTICAL ASSOCIATION | 1 | 2007 |
| MERCK & COMPANY INC | 1 | 2006 |
Issues relating to prescription drugs in health care bills; orphan drug and rare disease bill; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment Act of 2013 (H.R. 460); MODDERN Cures Act (H.R. 3116); H.R. 5657, the FAST Generics Act of 2014; tax extenders package; 21st Century Cures; H.R. 5780, the Protecting the Integrity of Medicare Act.
Patients' Access to Treatments Act of 2013
Client: CELGENE CORPORATION · Firm: ALSTON & BIRD LLP
Issues relating to prescription drugs in health care bills; orphan drug and rare disease bill; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment Act of 2013 (H.R. 460); MODDERN Cures Act (H.R. 3116); H.R. 5657, the FAST Generics Act of 2014; tax extenders package; 21st Century Cures; H.R. 5780, the Protecting the Integrity of Medicare Act.
Fair Access for Safe and Timely Generics Act of 2014
Client: CELGENE CORPORATION · Firm: ALSTON & BIRD LLP
Issues relating to prescription drugs in health care bills; orphan drug and rare disease bill; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment Act of 2013 (H.R. 460); MODDERN Cures Act (H.R. 3116); H.R. 5657, the FAST Generics Act of 2014; tax extenders package; 21st Century Cures; H.R. 5780, the Protecting the Integrity of Medicare Act.
Protecting the Integrity of Medicare Act of 2014
Client: CELGENE CORPORATION · Firm: ALSTON & BIRD LLP
Issues relating to prescription drugs in health care bills; orphan drug and rare disease bill; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment Act of 2013 (H.R. 460); MODDERN Cures Act (H.R. 3116); H.R. 5657, the FAST Generics Act of 2014; tax extenders package; 21st Century Cures; H.R. 5780, the Protecting the Integrity of Medicare Act.
Cancer Drug Coverage Parity Act of 2013
Client: CELGENE CORPORATION · Firm: ALSTON & BIRD LLP
Issues relating to prescription drugs in health care bills; orphan drug and rare disease bill; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment of 2013 (H.R. 460); MODDERN Cures Act (H.R. 3116); H.R. 5657, the FAST Generics Act of 2014; tax extenders package; 21st Century Cures; H.R. 5780, the Protecting the Integrity of Medicare Act.
Cancer Drug Coverage Parity Act of 2013
Client: CELGENE CORPORATION · Firm: ALSTON & BIRD LLP
Issues relating to prescription drugs in health care bills; Issues related to coding of products; orphan drug and rare disease bill; Family Cord Blood Banking Act; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment Act of 2013 (H.R. 460); MODDERN Cures Act of 2013 (H.R. 3116); Veterans access legislation (H.R. 3230/H.R. 4810); The America Invents Act; H.R. 5657, the FAST Generics Act of 2014.
Issues relating to prescription drugs in health care bills; Issues related to coding of products; orphan drug and rare disease bill; Family Cord Blood Banking Act; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment Act of 2013 (H.R. 460); MODDERN Cures Act of 2013 (H.R. 3116); Veterans access legislation (H.R. 3230/H.R. 4810); The America Invents Act; H.R. 5657, the FAST Generics Act of 2014.
Issues relating to prescription drugs in health care bills; orphan drug and rare disease bill; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment of 2013 (H.R. 460); MODDERN Cures Act (H.R. 3116); H.R. 5657, the FAST Generics Act of 2014; tax extenders package; 21st Century Cures; H.R. 5780, the Protecting the Integrity of Medicare Act.
Patients' Access to Treatments Act of 2013
Client: CELGENE CORPORATION · Firm: ALSTON & BIRD LLP
Issues relating to prescription drugs in health care bills; Issues related to coding of products; orphan drug and rare disease bill; Family Cord Blood Banking Act; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment Act of 2013 (H.R. 460); MODDERN Cures Act of 2013 (H.R. 3116); Veterans access legislation (H.R. 3230/H.R. 4810); The America Invents Act; H.R. 5657, the FAST Generics Act of 2014.
Patients' Access to Treatments Act of 2013
Client: CELGENE CORPORATION · Firm: ALSTON & BIRD LLP
Issues relating to prescription drugs in health care bills; orphan drug and rare disease bill; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment of 2013 (H.R. 460); MODDERN Cures Act (H.R. 3116); H.R. 5657, the FAST Generics Act of 2014; tax extenders package; 21st Century Cures; H.R. 5780, the Protecting the Integrity of Medicare Act.
Issues relating to prescription drugs in health care bills; Issues related to coding of products; orphan drug and rare disease bill; Family Cord Blood Banking Act; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment Act of 2013 (H.R. 460); MODDERN Cures Act of 2013 (H.R. 3116); Veterans access legislation (H.R. 3230/H.R. 4810); The America Invents Act; H.R. 5657, the FAST Generics Act of 2014.
Fair Access for Safe and Timely Generics Act of 2014
Client: CELGENE CORPORATION · Firm: ALSTON & BIRD LLP
Issues relating to prescription drugs in health care bills; Issues related to coding of products; orphan drug and rare disease bill; Family Cord Blood Banking Act; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment Act of 2013 (H.R. 460); MODDERN Cures Act of 2013 (H.R. 3116); Veterans access legislation (H.R. 3230/H.R. 4810); The America Invents Act; H.R. 5657, the FAST Generics Act of 2014.
Fair Access for Safe and Timely Generics Act of 2014
Client: CELGENE CORPORATION · Firm: ALSTON & BIRD LLP
Issues relating to prescription drugs in health care bills; orphan drug and rare disease bill; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment of 2013 (H.R. 460); MODDERN Cures Act (H.R. 3116); H.R. 5657, the FAST Generics Act of 2014; tax extenders package; 21st Century Cures; H.R. 5780, the Protecting the Integrity of Medicare Act.
Protecting the Integrity of Medicare Act of 2014
Client: CELGENE CORPORATION · Firm: ALSTON & BIRD LLP
Issues relating to prescription drugs in health care bills; orphan drug and rare disease bill; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment of 2013 (H.R. 460); MODDERN Cures Act (H.R. 3116); H.R. 5657, the FAST Generics Act of 2014; tax extenders package; 21st Century Cures; H.R. 5780, the Protecting the Integrity of Medicare Act.
PRO(TECH)T Act of 2008
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
S. 2041, False Claims Correction Act of 2007; H.R. 6357, PRO(TECH)T Act of 2008; Issues related to new Medicare requirements for the Advanced Beneficiary Notice.
False Claims Act Correction Act of 2008
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
S. 2041, False Claims Correction Act of 2007; H.R. 6357, PRO(TECH)T Act of 2008; Issues related to new Medicare requirements for the Advanced Beneficiary Notice.
PRO(TECH)T Act of 2008
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
False Claims Correction Act HR 6357 PRO(TECH)T Act of 2008 Issues related to Medicare requirements for the Advanced Beneficiary Notice
PRO(TECH)T Act of 2008
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
False Claims Correction Act H.R. 6357, PRO(TECH)T Act of 2008 Issues related to Medicare requirements for the Advanced Beneficiary Notice
PRO(TECH)T Act of 2008
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
False Claims Correction Act H.R. 6357, PRO(TECH)T Act of 2008 Issues related to Medicare requirements for the Advanced Beneficiary Notice Health Care Reform
PRO(TECH)T Act of 2008
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
S. 2041, False Claims Correction Act of 2007; H.R. 6357, PRO(TECH)T Act of 2008; Issues related to new Medicare requirements for the Advanced Beneficiary Notice.
PRO(TECH)T Act of 2008
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
S. 2041, False Claims Correction Act of 2007; H.R. 6357, PRO(TECH)T Act of 2008; Issues related to new Medicare requirements for the Advanced Beneficiary Notice.
False Claims Act Correction Act of 2008
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
S. 2041, False Claims Correction Act of 2007; H.R. 6357, PRO(TECH)T Act of 2008; Issues related to new Medicare requirements for the Advanced Beneficiary Notice.
False Claims Act Correction Act of 2008
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
S. 2041, False Claims Correction Act of 2007; H.R. 6357, PRO(TECH)T Act of 2008; Issues related to new Medicare requirements for the Advanced Beneficiary Notice.
Medicare Improvements for Patients and Providers Act of 2008
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008. Issues affecting the billing and payment of clinical laboratory services; CMS provisions dealing with "anti mark up" of diagnostic services FDA regulation of clinical laboratory testing.
PRO(TECH)T Act of 2008
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
S. 2041, False Claims Correction Act of 2007; H.R. 6357, PRO(TECH)T Act of 2008; Issues related to new Medicare requirements for the Advanced Beneficiary Notice.
PRO(TECH)T Act of 2008
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
S. 2041, False Claims Correction Act of 2007; H.R. 6357, PRO(TECH)T Act of 2008; Issues related to new Medicare requirements for the Advanced Beneficiary Notice.
False Claims Act Correction Act of 2008
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
S. 2041, False Claims Correction Act of 2007; H.R. 6357, PRO(TECH)T Act of 2008; Issues related to new Medicare requirements for the Advanced Beneficiary Notice.
False Claims Act Correction Act of 2008
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
S. 2041, False Claims Correction Act of 2007; H.R. 6357, PRO(TECH)T Act of 2008; Issues related to new Medicare requirements for the Advanced Beneficiary Notice.
Saving Our Community Pharmacies Act of 2007
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: ALSTON & BIRD LLP
H.R. 3162, The Childrens Health and Medicare Protection Act, managers amendment. AMP legislation: HR 3140, HR 3193, HR 3700/S. 1951, amendment language regarding submission and publication of AMP data. H.R. 976, H.R. 3963, S. 2499, Medicare, Medicaid, and SCHIP Extension Act of 2007.
Access to Community Pharmacy Preservation Act of 2007
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: ALSTON & BIRD LLP
H.R. 3162, The Childrens Health and Medicare Protection Act, managers amendment. AMP legislation: HR 3140, HR 3193, HR 3700/S. 1951, amendment language regarding submission and publication of AMP data. H.R. 976, H.R. 3963, S. 2499, Medicare, Medicaid, and SCHIP Extension Act of 2007.
Community Clinical Laboratory Fairness in Competition Act of 2007
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
"Anti-mark up" provisions related to billing and payment for laboratory services. H.R. 3453 & S. 2099, bills to repeal a competitive bidding demonstration project for clinical lab services. CMS issues related to the ordering, billing and payment for clinical laboratory testing. FDA regulation of clinical laboratory testing.
Community Clinical Laboratory Fairness in Competition Act of 2007
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
"Anti-mark up" provisions related to billing and payment for laboratory services. H.R. 3453 & S. 2099, bills to repeal a competitive bidding demonstration project for clinical lab services. CMS issues related to the ordering, billing and payment for clinical laboratory testing. FDA regulation of clinical laboratory testing.
Fair Medicaid Drug Payment Act of 2007
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: ALSTON & BIRD LLP
H.R. 3162, The Childrens Health and Medicare Protection Act, managers amendment. AMP legislation: HR 3140, HR 3193, HR 3700/S. 1951, amendment language regarding submission and publication of AMP data. H.R. 976, H.R. 3963, S. 2499, Medicare, Medicaid, and SCHIP Extension Act of 2007.
Children's Health Insurance Program Reauthorization Act of 2007
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: ALSTON & BIRD LLP
H.R. 3162, The Childrens Health and Medicare Protection Act, managers amendment. AMP legislation: HR 3140, HR 3193, HR 3700/S. 1951, amendment language regarding submission and publication of AMP data. H.R. 976, H.R. 3963, S. 2499, Medicare, Medicaid, and SCHIP Extension Act of 2007.
A bill to provide for the extension of transitional medical assistance (TMA) and the abstinence education program through the end of fiscal year 2007, and for other purposes.
Client: COALITION OF FULL SERVICE COMMUNITY HOSPITALS · Firm: ALSTON & BIRD LLP
H.R. 3162, The Children's Health and Medicare Protection Act, Sec. 651. Senate Finance Committee oversight and investigation of emergency calls from Arizona specialty hospitals. Proposed changes to physician self-referral policies in the CY08 Physician Fee Schedule Proposed Rule. S. 1701, U.S. Troop Readiness, Veterans' Care, Katrina Recovery and Iraq Accountability Appropriations Act of 2007, Section 7002(b) relating to delaying implementation of the tamper-resistant prescription pad law.
Fair Medicaid Drug Payment Act of 2007
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: ALSTON & BIRD LLP
H.R. 3162, The Childrens Health and Medicare Protection Act, managers amendment. AMP legislation: HR 3140, HR 3193, HR 3700/S. 1951, amendment language regarding submission and publication of AMP data. H.R. 976, H.R. 3963, S. 2499, Medicare, Medicaid, and SCHIP Extension Act of 2007.
Preserving Access to Laboratory Services Act of 2007
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
"Anti-mark up" provisions related to billing and payment for laboratory services. H.R. 3453 & S. 2099, bills to repeal a competitive bidding demonstration project for clinical lab services. CMS issues related to the ordering, billing and payment for clinical laboratory testing. FDA regulation of clinical laboratory testing.
Preserving Access to Laboratory Services Act of 2007
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
"Anti-mark up" provisions related to billing and payment for laboratory services. H.R. 3453 & S. 2099, bills to repeal a competitive bidding demonstration project for clinical lab services. CMS issues related to the ordering, billing and payment for clinical laboratory testing. FDA regulation of clinical laboratory testing.
Medicare, Medicaid, and SCHIP Extension Act of 2007
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: ALSTON & BIRD LLP
H.R. 3162, The Childrens Health and Medicare Protection Act, managers amendment. AMP legislation: HR 3140, HR 3193, HR 3700/S. 1951, amendment language regarding submission and publication of AMP data. H.R. 976, H.R. 3963, S. 2499, Medicare, Medicaid, and SCHIP Extension Act of 2007.
To require cigarette products to be placed under or behind the counter in retail sales.
Client: COALITION OF FULL SERVICE COMMUNITY HOSPITALS · Firm: ALSTON & BIRD LLP
H.R. 3162, The Children's Health and Medicare Protection Act, Sec. 651.
To require cigarette products to be placed under or behind the counter in retail sales.
Client: COALITION OF FULL SERVICE COMMUNITY HOSPITALS · Firm: ALSTON & BIRD LLP
H.R. 3162, The Children's Health and Medicare Protection Act, Sec. 651. Senate Finance Committee oversight and investigation of emergency calls from Arizona specialty hospitals. Proposed changes to physician self-referral policies in the CY08 Physician Fee Schedule Proposed Rule. S. 1701, U.S. Troop Readiness, Veterans' Care, Katrina Recovery and Iraq Accountability Appropriations Act of 2007, Section 7002(b) relating to delaying implementation of the tamper-resistant prescription pad law.
To require cigarette products to be placed under or behind the counter in retail sales.
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: ALSTON & BIRD LLP
H.R. 3162, The Childrens Health and Medicare Protection Act, managers amendment. AMP legislation: HR 3140, HR 3193, HR 3700/S. 1951, amendment language regarding submission and publication of AMP data. H.R. 976, H.R. 3963, S. 2499, Medicare, Medicaid, and SCHIP Extension Act of 2007.
Issues related to drug policy, including reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2017 · fourth_quarter · Q4
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2017 · third_quarter · Q3
Issues related to drug policy, including reimbursement.
Issues related to drug policy, including reimbursement.
Issues related to drug policy, including reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2017 · third_quarter · Q3
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2017 · second_quarter · Q2
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2017 · second_quarter · Q2
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Veterans Affairs, Dept of (VA)
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2015 · fourth_quarter · Q4
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2015 · fourth_quarter · Q4
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2015 · third_quarter · Q3
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2015 · third_quarter · Q3
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2015 · second_quarter · Q2
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2015 · second_quarter · Q2
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
CELGENE CORPORATION via ALSTON & BIRD LLP
2015 · first_quarter · Q1
Issues relating to prescription drugs in health care bills; orphan drug and rare disease bill; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment Act of 2013 (H.R. 460); MODDERN Cures Act (H.R. 3116); H.R. 5657, the FAST Generics Act of 2014; tax extenders package; 21st Century Cures; H.R. 5780, the Protecting the Integrity of Medicare Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2015 · first_quarter · Q1
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2015 · first_quarter · RR
Issues related to coverage and reimbursement of pharmaceuticals.
Issues related to coverage and reimbursement of pharmaceuticals.
Issues related to coverage and reimbursement of pharmaceuticals.
CELGENE CORPORATION via ALSTON & BIRD LLP
2014 · fourth_quarter · Q4
Issues relating to prescription drugs in health care bills; orphan drug and rare disease bill; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment of 2013 (H.R. 460); MODDERN Cures Act (H.R. 3116); H.R. 5657, the FAST Generics Act of 2014; tax extenders package; 21st Century Cures; H.R. 5780, the Protecting the Integrity of Medicare Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2014 · fourth_quarter · Q4
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
CELGENE CORPORATION via ALSTON & BIRD LLP
2014 · third_quarter · Q3
Issues relating to prescription drugs in health care bills; Issues related to coding of products; orphan drug and rare disease bill; Family Cord Blood Banking Act; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment Act of 2013 (H.R. 460); MODDERN Cures Act of 2013 (H.R. 3116); Veterans access legislation (H.R. 3230/H.R. 4810); The America Invents Act; H.R. 5657, the FAST Generics Act of 2014.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2014 · third_quarter · Q3
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2014 · second_quarter · Q2
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ASSOCIATION OF NURSE ANESTHETISTS via ALSTON & BIRD LLP
2014 · first_quarter · Q1
Healthcare reform implementation; provider nondiscrimination, physician supervision issues, and pain management issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2014 · first_quarter · Q1
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ASSOCIATION OF NURSE ANESTHETISTS via ALSTON & BIRD LLP
2013 · fourth_quarter · Q4
Healthcare reform implementation; provider nondiscrimination, physician supervision issues, and pain management issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2013 · fourth_quarter · Q4
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2013 · third_quarter · Q3
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ASSOCIATION OF NURSE ANESTHETISTS via ALSTON & BIRD LLP
2013 · third_quarter · Q3
Healthcare reform implementation; provider nondiscrimination, physician supervision issues, and pain management issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF NURSE ANESTHETISTS via ALSTON & BIRD LLP
2013 · second_quarter · Q2
Healthcare reform implementation; provider nondiscrimination, physician supervision issues, and pain management issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF HIP AND KNEE SURGEONS via ALSTON & BIRD LLP
2013 · second_quarter · Q2
Reimbursement of hip and knee surgery services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2013 · second_quarter · Q2
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ASSOCIATION OF NURSE ANESTHETISTS via ALSTON & BIRD LLP
2013 · first_quarter · Q1
Healthcare reform implementation; provider nondiscrimination, physician supervision issues, and pain management issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF HIP AND KNEE SURGEONS via ALSTON & BIRD LLP
2013 · first_quarter · Q1
Reimbursement of hip and knee surgery services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2013 · first_quarter · Q1
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BNN HOLDINGS CORP via ALSTON & BIRD LLP
2013 · first_quarter · RR
Medicare Physician Fee Schedule; Access to Intraoperative Neuromonitoring Services
Medicare Physician Fee Schedule; Access to Intraoperative Neuromonitoring Services
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2012 · fourth_quarter · 4A
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2012 · fourth_quarter · 4A
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ASSOCIATION OF NURSE ANESTHETISTS via ALSTON & BIRD LLP
2012 · fourth_quarter · Q4
Healthcare reform implementation; provider nondiscrimination, physician supervision issues, and pain management issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF HIP AND KNEE SURGEONS via ALSTON & BIRD LLP
2012 · fourth_quarter · Q4
Reimbursement of hip and knee surgery services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2012 · third_quarter · 3A
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2012 · third_quarter · Q3
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ASSOCIATION OF NURSE ANESTHETISTS via ALSTON & BIRD LLP
2012 · third_quarter · Q3
Healthcare reform implementation; provider nondiscrimination, physician supervision issues, and pain management issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF HIP AND KNEE SURGEONS via ALSTON & BIRD LLP
2012 · fourth_quarter · RR
Reimbursement of hip and knee surgery services.
AMERICAN ASSOCIATION OF NURSE ANESTHETISTS via ALSTON & BIRD LLP
2012 · second_quarter · Q2
Healthcare reform implementation; provider nondiscrimination, physician supervision issues, and pain management issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2012 · second_quarter · Q2
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2012 · first_quarter · Q1
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ASSOCIATION OF NURSE ANESTHETISTS via ALSTON & BIRD LLP
2012 · first_quarter · Q1
Healthcare reform implementation; provider nondiscrimination, physician supervision issues, and pain management issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF NURSE ANESTHETISTS via ALSTON & BIRD LLP
2011 · fourth_quarter · Q4
Healthcare reform implementation; provider nondiscrimination, physician supervision issues, and pain management issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via ALSTON & BIRD LLP
2011 · fourth_quarter · Q4
Medicare Program; Durable Medical Equipment; Proposed Rule (CMS-1577-P)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2011 · fourth_quarter · Q4
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INSULET CORPORATION via ALSTON & BIRD LLP
2011 · third_quarter · Q3
Medicare Program; Durable Medical Equipment; Proposed Rule (CMS-1577-P)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2011 · third_quarter · Q3
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ASSOCIATION OF NURSE ANESTHETISTS via ALSTON & BIRD LLP
2011 · third_quarter · Q3
Healthcare reform implementation; provider nondiscrimination, physician supervision issues, and pain management issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via ALSTON & BIRD LLP
2011 · second_quarter · Q2
Reimbursement issues for OmniPod System.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2011 · second_quarter · Q2
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INSULET CORPORATION via ALSTON & BIRD LLP
2011 · first_quarter · 1A
Reimbursement issues for OmniPod System.
Filing targets: Centers For Medicare and Medicaid Services (CMS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2011 · first_quarter · Q1
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INSULET CORPORATION via ALSTON & BIRD LLP
2010 · fourth_quarter · 4A
Reimbursement issues for OmniPod System.
Filing targets: Centers For Medicare and Medicaid Services (CMS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2010 · fourth_quarter · Q4
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INSULET CORPORATION via ALSTON & BIRD LLP
2010 · third_quarter · 3A
Reimbursement issues for OmniPod System.
Filing targets: Centers For Medicare and Medicaid Services (CMS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2010 · third_quarter · Q3
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INSULET CORPORATION via ALSTON & BIRD LLP
2010 · third_quarter · RR
Reimbursement issues for OmniPod System
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2010 · second_quarter · Q2
Payment and regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2010 · first_quarter · Q1
S. 2041, False Claims Correction Act of 2007; H.R. 6357, PRO(TECH)T Act of 2008; Issues related to new Medicare requirements for the Advanced Beneficiary Notice.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), SENATE
WRIGHT MEDICAL TECHNOLOGY, INC. via ALSTON & BIRD LLP
2009 · fourth_quarter · Q4
CMS best coverage decisions
CMS best coverage decisions
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2009 · fourth_quarter · Q4
False Claims Correction Act H.R. 6357, PRO(TECH)T Act of 2008 Issues related to Medicare requirements for the Advanced Beneficiary Notice Health Care Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), SENATE
WRIGHT MEDICAL TECHNOLOGY, INC. via ALSTON & BIRD LLP
2009 · third_quarter · Q3
CMS best coverage decisions
CMS best coverage decisions
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2009 · third_quarter · Q3
False Claims Correction Act H.R. 6357, PRO(TECH)T Act of 2008 Issues related to Medicare requirements for the Advanced Beneficiary Notice
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), SENATE
WRIGHT MEDICAL TECHNOLOGY, INC. via ALSTON & BIRD LLP
2009 · second_quarter · Q2
CMS best coverage decisions.
CMS best coverage decisions.
WRIGHT MEDICAL TECHNOLOGY, INC. via ALSTON & BIRD LLP
2009 · first_quarter · Q1
CMS best coverage decisions.
CMS best coverage decisions.
WRIGHT MEDICAL TECHNOLOGY, INC. via ALSTON & BIRD LLP
2009 · first_quarter · RR
CMS best coverage decisions.
CMS best coverage decisions.
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2009 · second_quarter · Q2
False Claims Correction Act HR 6357 PRO(TECH)T Act of 2008 Issues related to Medicare requirements for the Advanced Beneficiary Notice
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), SENATE
PROSTRAKAN INC via ALSTON & BIRD LLP
2009 · second_quarter · Q2
CMS coverage decision for anti-emetics.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PROSTRAKAN INC via ALSTON & BIRD LLP
2009 · first_quarter · Q1
CMS coverage decision for anti-emetics.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2009 · first_quarter · Q1
S. 2041, False Claims Correction Act of 2007; H.R. 6357, PRO(TECH)T Act of 2008; Issues related to new Medicare requirements for the Advanced Beneficiary Notice.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2009 · fourth_quarter · Q4
S. 2041, False Claims Correction Act of 2007; H.R. 6357, PRO(TECH)T Act of 2008; Issues related to new Medicare requirements for the Advanced Beneficiary Notice.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2008 · fourth_quarter · 4A
S. 2041, False Claims Correction Act of 2007; H.R. 6357, PRO(TECH)T Act of 2008; Issues related to new Medicare requirements for the Advanced Beneficiary Notice.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2008 · third_quarter · Q3
S. 2041, False Claims Correction Act of 2007; H.R. 6357, PRO(TECH)T Act of 2008; Issues related to new Medicare requirements for the Advanced Beneficiary Notice.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), SENATE
PROSTRAKAN INC via ALSTON & BIRD LLP
2008 · second_quarter · Q2
Issues relating to Medicare reimbursement for pharmaceuticals.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2008 · second_quarter · Q2
H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008. Issues affecting the billing and payment of clinical laboratory services; CMS provisions dealing with "anti mark up" of diagnostic services FDA regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2008 · first_quarter · Q1
"Anti-mark up" provisions related to billing and payment for laboratory services. CMS issues related to the ordering, billing and payment for clinical laboratory testing. FDA regulation of clinical laboratory testing.
"Anti-mark up" provisions related to billing and payment for laboratory services. CMS issues related to the ordering, billing and payment for clinical laboratory testing. FDA regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PROSTRAKAN INC via ALSTON & BIRD LLP
2008 · first_quarter · RR
Issues relating to Medicare reimbursement for pharmaceuticals.
Issues relating to Medicare reimbursement for pharmaceuticals.
Issues relating to Medicare reimbursement for pharmaceuticals.
COALITION OF FULL SERVICE COMMUNITY HOSPITALS via ALSTON & BIRD LLP
2007 · year_end · YA
H.R. 3162, The Children's Health and Medicare Protection Act, Sec. 651. Senate Finance Committee oversight and investigation of emergency calls from Arizona specialty hospitals. Proposed changes to physician self-referral policies in the CY08 Physician Fee Schedule Proposed Rule. S. 1701, U.S. Troop Readiness, Veterans' Care, Katrina Recovery and Iraq Accountability Appropriations Act of 2007, Section 7002(b) relating to delaying implementation of the tamper-resistant prescription pad law.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, UNDETERMINED
BRACCO DIAGNOSTICS INC via ALSTON & BIRD LLP
2007 · mid_year · RR
Hospital Outpatient Department Prospective Payment System reform for radiopharmaceuticals.
GENERIC PHARMACEUTICAL ASSOCIATION via ALSTON & BIRD LLP
2007 · year_end · YY
H.R. 3162, The Childrens Health and Medicare Protection Act, managers amendment. AMP legislation: HR 3140, HR 3193, HR 3700/S. 1951, amendment language regarding submission and publication of AMP data. H.R. 976, H.R. 3963, S. 2499, Medicare, Medicaid, and SCHIP Extension Act of 2007.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2007 · year_end · YY
"Anti-mark up" provisions related to billing and payment for laboratory services. H.R. 3453 & S. 2099, bills to repeal a competitive bidding demonstration project for clinical lab services. CMS issues related to the ordering, billing and payment for clinical laboratory testing. FDA regulation of clinical laboratory testing.
"Anti-mark up" provisions related to billing and payment for laboratory services. H.R. 3453 & S. 2099, bills to repeal a competitive bidding demonstration project for clinical lab services. CMS issues related to the ordering, billing and payment for clinical laboratory testing. FDA regulation of clinical laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION OF FULL SERVICE COMMUNITY HOSPITALS via ALSTON & BIRD LLP
2007 · year_end · YY
H.R. 3162, The Children's Health and Medicare Protection Act, Sec. 651.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2007 · mid_year · MA
Regulation of clinical laboratories and laboratory testing; Medicare reimbursement; Oversight of laboratory testing
Regulation of clinical laboratories and laboratory testing; Medicare reimbursement; Oversight of laboratory testing
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2007 · mid_year · MM
Direct to Consumer drug issues
Filing targets: Food & Drug Administration (FDA)
GENOMIC HEALTH INC via ALSTON & BIRD LLP
2006 · year_end · YY
Reimbursement of laboratory testing services
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MERCK & COMPANY INC via ALSTON & BIRD LLP
2006 · year_end · YY
vaccine access, CMS payment of vaccine administrative costs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2006 · year_end · YY
competitive bidding demonstration project, physician fee payment schedules, laboratory development test guidance
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Office of Management & Budget (OMB)